Drug Shortage Report for ERYTHRO-ES
Report ID | 3752 |
Drug Identification Number | 00637416 |
Brand name | ERYTHRO-ES |
Common or Proper name | ERYTHRO-ES |
Company Name | AA PHARMA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ERYTHROMYCIN |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 Bottle |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2015-06-24 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2019-01-15 |
Shortage status | Resolved |
Updated date | 2020-08-06 |
Company comments | product discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-08-06 | French | Compare |
v3 | 2020-08-06 | English | Compare |
v2 | 2017-03-21 | French | Compare |
v1 | 2017-03-21 | English | Compare |
Showing 1 to 4 of 4